Storr Liver Centre, Faculty of Medicine and Health, Westmead Clinical School and Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW 2145, Australia.
Centre for Infectious Diseases and Microbiology, Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.
Viruses. 2021 Jan 26;13(2):180. doi: 10.3390/v13020180.
Hepatitis B Virus (HBV) is a globally-distributed pathogen and is a major cause of liver disease. HBV (or closely-related animal hepadnaviruses) can integrate into the host genome, but (unlike retroviruses) this integrated form is replication-defective. The specific role(s) of the integrated HBV DNA has been a long-standing topic of debate. Novel in vitro models of HBV infection combined with sensitive molecular assays now enable researchers to investigate this under-characterised phenomenon with greater ease and precision. This review covers the contributions these systems have made to understanding how HBV DNA integration induces liver cancer and facilitates viral persistence. We summarise the current findings into a working model of chronic HBV infection and discuss the clinical implications of this hypothetical framework on the upcoming therapeutic strategies used to curb HBV-associated pathogenesis.
乙型肝炎病毒 (HBV) 是一种分布广泛的病原体,也是导致肝脏疾病的主要原因。HBV(或密切相关的动物嗜肝病毒)可以整合到宿主基因组中,但(与逆转录病毒不同)这种整合形式是复制缺陷的。整合 HBV DNA 的具体作用一直是一个长期存在的争论话题。新型 HBV 感染体外模型结合敏感的分子检测方法,现在使研究人员能够更轻松、更精确地研究这一特征尚未明确的现象。本综述介绍了这些系统在理解 HBV DNA 整合如何诱导肝癌和促进病毒持续存在方面的贡献。我们将当前的研究结果总结成一个慢性 HBV 感染的工作模型,并讨论这个假设框架对即将用于抑制 HBV 相关发病机制的治疗策略的临床意义。